Which iron pill is best for Moms-to-Be? new study aims to find out

NCT ID NCT06014983

First seen May 06, 2026 · Last updated Jun 19, 2026 · Updated 8 times

Summary

This study compares two forms of iron (ferrous fumarate and ferrous bisglycinate) in daily prenatal supplements for 172 pregnant women in Vancouver. Researchers will measure iron levels in blood and stool samples to see which form is better absorbed and causes fewer side effects. The goal is to improve guidelines for preventing iron deficiency during pregnancy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IRON-DEFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • BC Women's Hospital

    RECRUITING

    Vancouver, British Columbia, V6H 3N1, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of British Columbia, Food, Nutrition and Health Building

    RECRUITING

    Vancouver, British Columbia, V6T 1Z4, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

iron supplements (ferrous fumarate or ferrous bisglycinate)

What this could lead to

If successful, this could help doctors recommend the best type of iron supplement for pregnant women to prevent iron deficiency.

What could go wrong

This is a small, early-stage study with only 172 participants, so results may not apply to all pregnant women. It compares two common supplements, not a new treatment.

Conditions

The condition(s) this trial relates to.

Iron Deficiencies iron deficiency anemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.